Economy

News on Indian Economy

India and Japan Push Strategic Tech Partnership in Critical Minerals, Semiconductors and ICT

At the centre of the discussions was a shared concern: modern economic power now depends on trusted supply chains for minerals, chips, telecom systems, artificial intelligence, clean energy equipment and advanced manufacturing. The MEA said both sides discussed industrial and technological collaboration in five major sectors — critical minerals, semiconductors, ICT including AI and telecom, clean energy and pharmaceuticals — and agreed on the need for stronger public-private partnerships to protect economic interests and build resilient supply chains.

India Post’s APT 2.0 Pushes Branch Offices Toward Real-Time, AI-Led Governance

APT 2.0 is aimed at changing how postal branches function on the ground. Instead of depending only on manual reporting and delayed administrative feedback, branch offices can now use digital insights to study local demand, track service performance and respond more quickly to customer needs. This gives India Post a more data-driven operating model, especially in rural and semi-urban areas where postal services remain a critical public interface.

Mizoram Ginger Mission Launched With ₹189.79 Crore Push for Farmer Value Addition and Global Branding

The initiative is particularly important because Mizoram is known for its GI-certified ginger cultivars, which have strong potential in pharma-grade and premium global markets. According to the PIB release, Mizo ginger contains 6 to 8 percent oleoresin, compared with the global average of around 3 percent. Despite this quality advantage, farmers currently receive only around ₹8 to ₹15 per kilogram, while the value chain can reach more than ₹500 per kilogram in international markets.

Indian Pharma Giants Commit $19.1 Billion to US Expansion, Signalling a New Phase in Global Growth

The list of participating Indian pharma companies includes some of the country’s biggest names: Aurobindo Pharma, Biocon Group, Cipla, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Granules India, Jubilant Group, Lupin, Sun Pharmaceutical Industries, Piramal Pharma and Zydus Lifesciences. Their proposed investments are expected to support new manufacturing facilities, expansion of existing networks, research and development centres and broader supply-chain capacity in the United States.

India Plans ‘Made in India’ Brand Scheme to Strengthen Domestic Manufacturing and Cut Import Dependence

The government is working with industry to identify around 100 products that are either not manufactured in India or are produced in inadequate quantities. The focus is not merely on replacing imports, but on building production capacity in areas where India already has industrial capability but faces technology, scale or supply-chain gaps. According to Bhatia, several “unique and interesting” products have already been identified, including auto-sector items such as axles and motorcycle components.

India Rises to Third Globally in Installed Renewable Energy Capacity, but Supply Chain Gaps Remain

News On Air reported that India’s non-fossil fuel capacity has crossed 50 percent of total installed capacity, reaching 262.7 gigawatts. It also noted that solar and wind energy account for the bulk of recent additions. Official MNRE figures released earlier said India had installed 283.46 GW of non-fossil fuel capacity as of March 31, 2026, including 274.68 GW from renewable energy and 8.78 GW from nuclear power.